Per Montgomery County:
Greetings,
Message from the County Executive Marc Elrich on Reducing Quarantines in Schools, Vaccines, and More
covid
In a message to the community, MCPS has outlined changes to quarantine guidelines. The full message can be seen below:
Dear MCPS Community,
|
MCPS has been doing targeted outreach to school families to help them make appointments. More appointments for the weekend clinics will be coming online later this morning. We expect supply to ramp up quickly but currently, supply is limited and demand is high.
— Montgomery County DHHS (@MoCoDHHS) November 5, 2021
Per Montgomery County:
We will offer COVID-19 vaccine doses to children ages 5 to 11 beginning Thursday, November 4. Appointments are required.
Below you’ll see notes from Governor Larry Hogan’s 11/3 press conference, as tweeted by his Deputy Communications Director, Kata Hall:
• Earlier today, Maryland health officials authorized providers across the state to immediately begin scheduling appointments, holding clinics, and vaccinating 5- to 11-year-olds.
Per the Montgomery County Department of Health and Human Services:
For Immediate Release: Wednesday, November 3, 2021
Press Release from the Montgomery County Council:
Council Approves Amended Board of Health Regulation Requiring Seven Consecutive Days of Substantial COVID-19 Transmission Before Implementing Indoor Mask Mandate in Public Spaces
The new regulation will reinstate the mask mandate after seven straight days of “substantial transmission”, which is 50 or above cases per 100,000 residents.
The mask mandate would go back into effect on Tuesday, November 9. As of Tuesday, there have been five consecutive days where the case rate has been above 50. The seventh consecutive day would technically be November 5, but there is a four-day grace period to allow numbers to be confirmed with CDC data.
This Week: Tuesday – Saturday
The Montgomery County Council, acting as the Board of Health, meets tomorrow (Tuesday) to vote on an amended version of the mask mandate. The changes would reinstitute the mandate after seven straight days of “substantial transmission”, which is 50 or above cases per 100,000 residents.
At today’s media briefing, Council President Tom Hucker stated that if the amendment was approved, the mask mandate would go back into effect on Tuesday, November 9. As of Monday, there have been four consecutive days where the case rate has been above 50. The seventh consecutive day would technically be November 5, but there is a four-day grace period to allow numbers to be confirmed with CDC data.
Novavax, a Gaithersburg-based biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine manufacturer by volume, today announced that the National Agency of Drug and Food Control of the Republic of Indonesia, or Badan Peng was Obat dan Makanan (Badan POM), has granted emergency use authorization (EUA) for Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant. It will be manufactured by SII in India and marketed by SII in Indonesia under the brand name COVOVAX™.
“The first authorization of Novavax’ COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia, which despite being the fourth most populous nation on earth, continues to work to procure sufficient vaccine for its population,” said Stanley C. Erck, President and Chief Executive Officer, Novavax. “This also marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favorable safety profile. This is a landmark moment for Novavax and our partner, Serum Institute of India, and it is the first of many authorizations that Novavax expects in the coming weeks and months for our vaccine globally.”